Zenas BioPharma, Inc. Common Stock (ZBIO) — Cash Flow Quality Index
Latest as of September 2023:
0.89x
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Cash Flow Quality Index of 0.89x as of September 2023. Operating cash flow of $31.85 Million is below net income of $35.61 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ZBIO cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
0.89x
Operating CF / Net Income
Operating Cash Flow
$31.85 Million
USD
Net Income
$35.61 Million
USD
Data as of
Sep 2023
Most recent filing
Annual Cash Flow Quality Index for Zenas BioPharma, Inc. Common Stock (None–None)
Year-by-year earnings quality comparison for Zenas BioPharma, Inc. Common Stock. For live market cap and the full company financial profile, see Zenas BioPharma, Inc. Common Stock market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.